Evaluation
*
Strongly disagreeDisagreeSlightly disagreeNeitherSlightly agreeAgreeStrongly agree
The activity presented balanced, evidence-based content free of commercial bias.
The presenter(s) used an effective teaching strategy.
The presentation slides / digital materials / resources and handouts were high quality.
The content was relevant to / useful for my professional practice.
The activity contributed to my knowledge, skills, and capacity to enhance the delivery of patient care.
The overall quality of the educational activity was excellent.
The venue for the activity was accessible, clean, and accommodating for learning.
*
Strongly disagreeDisagreeSlightly disagreeNeitherSlightly agreeAgreeStrongly agree
Janique Parnell, LCSW HQDA DCS – G1
Victor Rubio-Villanueava, LCSW
Cindy Morita, DSW, LCSW, HQDA – G1
Traci Waters, MS, MBA
Jason S. Moorash, LCSW
*
Strongly disagreeDisagreeSlightly disagreeNeitherSlightly agreeAgreeStrongly agree
Explain the Family Advocacy Program (FAP) Prevention’s Mission.
Differentiate between awareness campaigns and skill-building activities.
Identify a resource for implementing an effective prevention activity.
Explain the role of collaboration in developing effective prevention strategies.
Summarize how the fatality reviews process shifts the focus from individual incidents responses to identifying systemic gaps and trends.
Apply the Public Health Approach to prevention approach and strategies through mock fatality reviews.
Identify individual behavior that contributes to conflict in relationships.
Outline skills to help individuals and couples implement healthy behaviors to minimize the risk of conflict and abuse.
Discuss conflict resolution models and safety planning strategies to their clients.
Analyze the impact of limited staffing on client service delivery and program outcomes.
Identify effective strategies and services that support care delivery in a resource-limited environment.
Explain how drug misuse affects the immature brain and define high potency THC (Tetrahydrocannabinol).
Identify loopholes regarding synthetic cannabinoids.
*
*
*
*
*
*
*